The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Soft Tissue X-Ray Could Help Cystic Fibrosis Patients
A new X-ray system that allows the imaging of soft tissue could be used to non-invasively track the effectiveness of treatments for cystic fibrosis.
10 Medical Devices That Changed The World
Medical devices may sound like a modern invention, but they in fact have helped us manage and treat diseases for centuries. Here are our top ten picks of medical gadgets that play a significant role in our lives, many of them so ubiquitous that we sometimes take them for granted.
WuXi Begins Construction Of New Facility In Philadelphia
WuXi PharmaTech's intended 45,000 square feet facility will be for the manufacture of cell-based therapeutics.
WuXi To Offer Foundation’s Genomic Profiling In China
WuXi has been licensed to perform the FoundationOne® assay, providing the best-in-class genomics platform to biopharmaceuticals in China.
WuXi To Build Third Cell Therapy Facility
The company's third cell therapy manufacturing facility will focus on chimeric antigen receptor T cells for cancer immunotherapy.
AstraZeneca Expands Presence in Asia With Deals in China and Japan
AstraZeneca has entered a strategic alliance with WuXi AppTech and acquired Takeda's respiratory business.
The Cells That Enable Zebrafish To Regenerate Bone
Scientists in Japan have identified a group of progenitor cells that are maintained throughout adulthood and are responsible for bone regeneration.
CiRA & Takeda Announce Joint iPS Cell Research
Takeda, Japan's largest pharmaceutical company, will provide US$166 million of funding for iPS research over the next ten years.
Neglected No More
Dr. BT Slingsby, founder and CEO of the Global Health Innovative Technology (GHIT) fund, is passionate about using Japanese research knowhow to help tackle the most challenging public health issues of the day.